SGK3 and prostate carcinoma: Of note, the frequency of SGK3 gene amplification is particularly high in the SUC2/PCF IDT metastatic prostate adenocarcinoma dataset (Table S3), underlining the need for future studies to establish how SGKs contribute to prostate cancer and metastatic progression.